$USPH
U S PHYSICAL THERAPY INC /NV

2013 Q2 Form 10-Q Financial Statement

#000119312513325579 Filed on August 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $66.87M $63.40M
YoY Change 5.48% 5.84%
Cost Of Revenue $49.30M $45.60M
YoY Change 8.11% 6.05%
Gross Profit $17.31M $16.99M
YoY Change 1.84% 0.56%
Gross Profit Margin 25.88% 26.81%
Selling, General & Admin $6.500M $6.300M
YoY Change 3.17% 5.0%
% of Gross Profit 37.56% 37.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.380M $1.320M
YoY Change 4.55% -7.04%
% of Gross Profit 7.97% 7.77%
Operating Expenses $6.500M $6.300M
YoY Change 3.17% 5.0%
Operating Profit $11.06M $10.81M
YoY Change 2.34% -0.86%
Interest Expense $130.0K $145.0K
YoY Change -10.34% -245.0%
% of Operating Profit 1.18% 1.34%
Other Income/Expense, Net
YoY Change
Pretax Income $10.56M $10.45M
YoY Change 0.97% -3.2%
Income Tax $3.181M $3.140M
% Of Pretax Income 30.14% 30.04%
Net Earnings $4.914M $4.849M
YoY Change 1.34% -1.04%
Net Earnings / Revenue 7.35% 7.65%
Basic Earnings Per Share $0.41 $0.40
Diluted Earnings Per Share $0.41 $0.40
COMMON SHARES
Basic Shares Outstanding 12.09M shares 12.09M shares
Diluted Shares Outstanding 12.11M shares 12.11M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.30M $8.800M
YoY Change 17.05% -2.22%
Cash & Equivalents $10.29M $8.811M
Short-Term Investments
Other Short-Term Assets $1.878M $5.300M
YoY Change -64.57% 1.92%
Inventory
Prepaid Expenses
Receivables $29.30M $30.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $41.43M $44.60M
YoY Change -7.11% 0.68%
LONG-TERM ASSETS
Property, Plant & Equipment $13.76M $12.90M
YoY Change 6.64% 1.57%
Goodwill $112.2M
YoY Change
Intangibles $14.03M
YoY Change
Long-Term Investments
YoY Change
Other Assets $967.0K $1.400M
YoY Change -30.93% -57.58%
Total Long-Term Assets $141.0M $126.0M
YoY Change 11.91% 22.93%
TOTAL ASSETS
Total Short-Term Assets $41.43M $44.60M
Total Long-Term Assets $141.0M $126.0M
Total Assets $182.4M $170.6M
YoY Change 6.93% 16.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.300M $1.400M
YoY Change -7.14% -6.67%
Accrued Expenses $15.30M $14.20M
YoY Change 7.73% 11.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $800.0K $600.0K
YoY Change 33.33% 50.0%
Total Short-Term Liabilities $17.37M $16.20M
YoY Change 7.24% 10.2%
LONG-TERM LIABILITIES
Long-Term Debt $16.15M $20.30M
YoY Change -20.44% 26.09%
Other Long-Term Liabilities $706.0K $1.600M
YoY Change -55.88% 14.29%
Total Long-Term Liabilities $16.86M $21.90M
YoY Change -23.03% 25.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.37M $16.20M
Total Long-Term Liabilities $16.86M $21.90M
Total Liabilities $35.20M $55.30M
YoY Change -36.35% 25.11%
SHAREHOLDERS EQUITY
Retained Earnings $117.5M
YoY Change
Common Stock $38.71M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $31.63M
YoY Change
Treasury Stock Shares 2.215M shares
Shareholders Equity $124.6M $115.3M
YoY Change
Total Liabilities & Shareholders Equity $182.4M $170.6M
YoY Change 6.93% 16.21%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $4.914M $4.849M
YoY Change 1.34% -1.04%
Depreciation, Depletion And Amortization $1.380M $1.320M
YoY Change 4.55% -7.04%
Cash From Operating Activities $15.87M $13.80M
YoY Change 15.0% 93.28%
INVESTING ACTIVITIES
Capital Expenditures -$1.120M -$1.040M
YoY Change 7.69% 67.74%
Acquisitions
YoY Change
Other Investing Activities -$5.890M -$6.230M
YoY Change -5.46% -60.74%
Cash From Investing Activities -$7.010M -$7.270M
YoY Change -3.58% -55.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.850M -8.150M
YoY Change 8.59% -206.12%
NET CHANGE
Cash From Operating Activities 15.87M 13.80M
Cash From Investing Activities -7.010M -7.270M
Cash From Financing Activities -8.850M -8.150M
Net Change In Cash 10.00K -1.620M
YoY Change -100.62% -3.57%
FREE CASH FLOW
Cash From Operating Activities $15.87M $13.80M
Capital Expenditures -$1.120M -$1.040M
Free Cash Flow $16.99M $14.84M
YoY Change 14.49% 91.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
175000
CY2013Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
43 State
CY2012Q2 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.70 pure
CY2012Q2 usph Percentage Of Tax Deductible Goodwill
PercentageOfTaxDeductibleGoodwill
0.70 pure
CY2012Q2 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
250000
CY2013Q1 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1.00 pure
CY2013Q1 us-gaap Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value
BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
5428000
CY2013Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
719000
CY2013Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
1349000
CY2013Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-242000
CY2013Q1 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
14400000
CY2013Q1 usph Payments To Acquire Businesses Consideration
PaymentsToAcquireBusinessesConsideration
10798000
CY2013Q1 usph Business Combination Cost Of Acquire Entity Purchase Price
BusinessCombinationCostOfAcquireEntityPurchasePrice
5000
CY2013Q1 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
800000
CY2013Q1 usph Business Acquisition Purchase Price Allocation Net Tangible Asset
BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
1826000
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12106424 shares
CY2009Q1 usph Purchase Of Common Stock Under Credit Agreement
PurchaseOfCommonStockUnderCreditAgreement
15000000
CY2009Q1 usph Maximum Percentage Of Repurchase Of Common Stock
MaximumPercentageOfRepurchaseOfCommonStock
0.10 pure
CY2009Q1 usph Repurchases Of Common Stock
RepurchasesOfCommonStock
1200000 shares
CY2009Q1 usph Bank Credit Agreement To Permit Share Repurchases Of Common Stock
BankCreditAgreementToPermitShareRepurchasesOfCommonStock
15000000
CY2012Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8811000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
18034000
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1.00 pure
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14319911 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15298000
CY2013Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
15750000
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16150000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45588000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17373000
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
415000
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
147229000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
706000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
124624000
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38571000
CY2013Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
800000
CY2013Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q2 us-gaap Minority Interest
MinorityInterest
22605000
CY2013Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15750000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
117538000
CY2013Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1275000
CY2013Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
972000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
143000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
182430000
CY2013Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
400000
CY2013Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
400000
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
16950000
CY2013Q2 us-gaap Liabilities
Liabilities
35201000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
800000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
41429000
CY2013Q2 us-gaap Goodwill
Goodwill
112248000
CY2013Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
21404000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14029000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
967000
CY2013Q2 us-gaap Assets
Assets
182430000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10287000
CY2012Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
17400000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
111321000
CY2012Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1732000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
59345000
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1878000
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13757000
CY2013Q2 usph Allowance For Doubtful Accounts Accounts Receivable Other
AllowanceForDoubtfulAccountsAccountsReceivableOther
412000
CY2013Q2 usph Number Of Clinics Operated
NumberOfClinicsOperated
449 Clinic
CY2013Q2 usph Line Of Credit Facility Special Dividend Payable
LineOfCreditFacilitySpecialDividendPayable
0.40
CY2013Q2 usph Accounts Receivable Other
AccountsReceivableOther
1700000
CY2013Q2 usph Expected Reduction In Medicare Spending Percentage
ExpectedReductionInMedicareSpendingPercentage
0.02 pure
CY2013Q2 usph Furniture And Equipment Gross
FurnitureAndEquipmentGross
37941000
CY2013Q2 usph Business Acquisition Purchase Price Allocation Referral Relationships
BusinessAcquisitionPurchasePriceAllocationReferralRelationships
800000
CY2013Q2 usph Patient Accounts Receivable
PatientAccountsReceivable
27564000
CY2013Q2 usph Leverage Ratios
LeverageRatios
Less than 1.0 to 1.0
CY2013Q2 usph Business Combination Cost Of Acquire Entity Purchase Price
BusinessCombinationCostOfAcquireEntityPurchasePrice
95000
CY2013Q2 usph Business Acquisition Purchase Price Allocation Trade Name
BusinessAcquisitionPurchasePriceAllocationTradeName
1300000
CY2013Q2 usph Allowance For Doubtful Accounts Patient Accounts Receivable
AllowanceForDoubtfulAccountsPatientAccountsReceivable
1469000
CY2008Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2250000 shares
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9983000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14129651 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2214737 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14116000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
17575000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44158000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16307000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134659000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2279000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
117323000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
37489000
CY2012Q4 us-gaap Minority Interest
MinorityInterest
17336000
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
894000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
141000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
171714000
CY2012Q4 usph Allowance For Doubtful Accounts Accounts Receivable Other
AllowanceForDoubtfulAccountsAccountsReceivableOther
514000
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
20858000
CY2012Q4 usph Accounts Receivable Other
AccountsReceivableOther
1703000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12146000
CY2012Q4 usph Furniture And Equipment Gross
FurnitureAndEquipmentGross
36316000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1042000
CY2012Q4 us-gaap Assets
Assets
171714000
CY2012Q4 us-gaap Liabilities
Liabilities
37055000
CY2012Q4 us-gaap Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value
BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
2892000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
459000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
478000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
45322000
CY2012Q4 us-gaap Goodwill
Goodwill
100188000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
363000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11671000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
265000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57174000
CY2012Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-290000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5975000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2012Q4 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
8198000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13016000
CY2012Q4 usph Payments To Acquire Businesses Consideration
PaymentsToAcquireBusinessesConsideration
8279000
CY2012Q4 usph Business Acquisition Purchase Price Allocation Referral Relationships
BusinessAcquisitionPurchasePriceAllocationReferralRelationships
857000
CY2012Q4 usph Patient Accounts Receivable
PatientAccountsReceivable
25973000
CY2012Q4 usph Business Acquisition Purchase Price Allocation Trade Name
BusinessAcquisitionPurchasePriceAllocationTradeName
1300000
CY2012Q4 usph Allowance For Doubtful Accounts Patient Accounts Receivable
AllowanceForDoubtfulAccountsPatientAccountsReceivable
1595000
CY2012Q4 usph Business Acquisition Cost Of Acquired Entity Debt Issued
BusinessAcquisitionCostOfAcquiredEntityDebtIssued
350000
CY2012Q4 usph Business Acquisition Purchase Price Allocation Net Tangible Asset
BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
551000
dei Trading Symbol
TradingSymbol
USPH
dei Entity Registrant Name
EntityRegistrantName
U S PHYSICAL THERAPY INC /NV
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000885978
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12044000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12044000 shares
us-gaap Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
2015-08-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000 shares
us-gaap Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
2011-08-31
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20716000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
12022000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12022000 shares
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
15000
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
859499 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">U<b>se of Estimates</b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">In preparing the Company&#x2019;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, purchase accounting, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</font></p> </div>
us-gaap Interest Paid Net
InterestPaidNet
237000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
5428000
us-gaap Gross Profit
GrossProfit
31964000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1999000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2418000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
234000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9998000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
64200000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000
us-gaap Profit Loss
ProfitLoss
12983000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3867000
us-gaap Operating Income Loss
OperatingIncomeLoss
18835000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
3522000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
4410000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18573000
us-gaap Net Income Loss
NetIncomeLoss
8635000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
126800000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
33000
us-gaap Sales Revenue Net
SalesRevenueNet
130322000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2394000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4348000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
682000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
14400000
us-gaap Costs And Expenses
CostsAndExpenses
98358000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
20000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8659000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
33000
us-gaap Dividends Common Stock
DividendsCommonStock
2418000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
33000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-796000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5590000
usph Maximum Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage
MaximumDifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
0.01 pure
usph Percentage Reduction For Service In Office Or Other Non Institutional Settings
PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings
0.20 pure
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Income Tax Effects Allocated Directly To Equity Equity Transactions
IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions
34000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
1200000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
4410000
us-gaap Share Based Compensation
ShareBasedCompensation
1370000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2282000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1384000
us-gaap Interest Expense
InterestExpense
265000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
684000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13441000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
19000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
62550000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2730000
us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
112000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
457000
us-gaap Restructuring Charges
RestructuringCharges
26000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
70228000
usph Share Based Compensation Arrangement By Share Based Payment Share Granted To Employees Lapse In Equal Installments Description
ShareBasedCompensationArrangementByShareBasedPaymentShareGrantedToEmployeesLapseInEqualInstallmentsDescription
Shares granted to employees lapse in equal installments on the following four or five annual anniversaries of the date of grant.
usph Compensation Expense Restricted Stock
CompensationExpenseRestrictedStock
1370000
usph Effective Date Of Reduction In Medicare Physician Fee Payment Rate
EffectiveDateOfReductionInMedicarePhysicianFeePaymentRate
2013-04-01
usph Acquisitions Of Noncontrolling Interests
AcquisitionsOfNoncontrollingInterests
1064000
usph Amount Of Reductions In Federal Spending
AmountOfReductionsInFederalSpending
1200000000000
usph Number Of Separate Transactions To Purchase Partnership Interest
NumberOfSeparateTransactionsToPurchasePartnershipInterest
6 Transactions
usph Treasury Stock Shares Retirement Period
TreasuryStockSharesRetirementPeriod
P7D
usph Additional Estimated Repurchase Of Common Stock
AdditionalEstimatedRepurchaseOfCommonStock
340501 shares
usph Reduction In Medicare Spending Percentage
ReductionInMedicareSpendingPercentage
0.02 pure
usph Number Of Physician Services Facilities
NumberOfPhysicianServicesFacilities
1 Facility
usph Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest Percent By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestPercentByParent
0.01 pure
usph Aggregate Losses Attributable To Non Controlling Interest
AggregateLossesAttributableToNonControllingInterest
37000
usph Increase Decrease In Accounts Receivable Other
IncreaseDecreaseInAccountsReceivableOther
-4000
usph Number Of Clinic Acquired
NumberOfClinicAcquired
1 Clinic
usph Percentage Increase In Payment Reduction In Institutional Or Non Institutional Setting
PercentageIncreaseInPaymentReductionInInstitutionalOrNonInstitutionalSetting
0.50 pure
usph Percentage Of Limited Partnership Interest Owned
PercentageOfLimitedPartnershipInterestOwned
0.64 pure
usph Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues
DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
0.01 pure
usph Business Acquisition Cost Of Acquired Entity Charge From Undistributed Earning
BusinessAcquisitionCostOfAcquiredEntityChargeFromUndistributedEarning
97000
usph Percentage Of General Partnership Interest Owned
PercentageOfGeneralPartnershipInterestOwned
0.01 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11872000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11872000 shares
usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
248000
usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
800000
usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
5 Partnership
usph Interest And Other Income Net
InterestAndOtherIncomeNet
3000
usph Increase Decrease In Patient Accounts Receivable
IncreaseDecreaseInPatientAccountsReceivable
2542000
usph Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Amount Changes Purchase Consideration Charge From Undistributed Earning
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestAmountChangesPurchaseConsiderationChargeFromUndistributedEarning
1100000
usph Aggregate Losses Tax Effect Attributable To Non Controlling Interest
AggregateLossesTaxEffectAttributableToNonControllingInterest
14000
usph Rent Clinic Supplies Contract Labor And Other
RentClinicSuppliesContractLaborAndOther
25822000
usph Loss On Sale Or Abandonment Of Assets Net
LossOnSaleOrAbandonmentOfAssetsNet
84000
usph Percentage Reduction For Service In Institutional Settings
PercentageReductionForServiceInInstitutionalSettings
0.25 pure
usph Period Of Federal Debt Ceiling In Connection With Deficit Reductions
PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions
P10Y
usph Corporate Office Costs
CorporateOfficeCosts
13129000
usph Percentage Of Practice Expense Component Of Relative Value Unit
PercentageOfPracticeExpenseComponentOfRelativeValueUnit
1.00 pure
usph Percentage Of Reduction Prevented
PercentageOfReductionPrevented
0.265 pure
usph Minimum Percentage Of Fair Value Reporting Unit Less Than Carrying Amount
MinimumPercentageOfFairValueReportingUnitLessThanCarryingAmount
0.50 pure
usph Goodwill Allocated To Specific Assets
GoodwillAllocatedToSpecificAssets
2340000
usph Minimum Difference Between Actual Aggregate Contractual Reserve Percentages Compared To Estimated Contractual Allowance Reserve Percentage
MinimumDifferenceBetweenActualAggregateContractualReservePercentagesComparedToEstimatedContractualAllowanceReservePercentage
0.01 pure
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
118000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18967000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11754000 shares
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
20165000
us-gaap Net Income Loss
NetIncomeLoss
9327000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
122551000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11754000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
126541000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3886000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2117000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
184000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7180000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
35900000
us-gaap Profit Loss
ProfitLoss
14126000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-301000
us-gaap Operating Income Loss
OperatingIncomeLoss
20469000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
3990000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
4751000
us-gaap Interest Paid Net
InterestPaidNet
422000
us-gaap Gross Profit
GrossProfit
33127000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1943000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4799000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-693000
us-gaap Costs And Expenses
CostsAndExpenses
93414000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
50000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10318000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
184000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1046000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
28000
us-gaap Share Based Compensation
ShareBasedCompensation
1043000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2397000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1172000
us-gaap Interest Expense
InterestExpense
307000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9821000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
31000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
32400000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2646000
us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
381000
us-gaap Restructuring Charges
RestructuringCharges
71000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
65470000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6039000
usph Acquisitions Of Noncontrolling Interests
AcquisitionsOfNoncontrollingInterests
726000
usph Increase Decrease In Accounts Receivable Other
IncreaseDecreaseInAccountsReceivableOther
400000
usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
350000
usph Interest And Other Income Net
InterestAndOtherIncomeNet
3000
usph Increase Decrease In Patient Accounts Receivable
IncreaseDecreaseInPatientAccountsReceivable
1613000
usph Corporate Office Costs
CorporateOfficeCosts
12658000
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9998000
CY2012Q2 usph Number Of Clinic Acquired
NumberOfClinicAcquired
7 Clinic
usph Rent Clinic Supplies Contract Labor And Other
RentClinicSuppliesContractLaborAndOther
25476000
usph Loss On Sale Or Abandonment Of Assets Net
LossOnSaleOrAbandonmentOfAssetsNet
83000
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.09
CY2012 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
7 Clinic
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7929000
CY2012 usph Number Of Outpatient Therapy Practices Purchased
NumberOfOutpatientTherapyPracticesPurchased
7 Transactions
CY2012 usph Number Of Transaction For Notes Payable Purchased
NumberOfTransactionForNotesPayablePurchased
1 Transactions
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11903000 shares
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11903000 shares
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
122000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11781000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11781000 shares
CY2012Q2 us-gaap Gross Profit
GrossProfit
16994000
CY2012Q2 us-gaap Profit Loss
ProfitLoss
7314000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
10598000
CY2012Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
1907000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10454000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
4849000
CY2012Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
62052000
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
63959000
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2465000
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
46965000
CY2012Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1280000
CY2012Q2 us-gaap Interest Expense
InterestExpense
145000
CY2012Q2 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
212000
CY2012Q2 us-gaap Restructuring Charges
RestructuringCharges
22000
CY2012Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
32671000
CY2012Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3140000
CY2012Q2 usph Interest And Other Income Net
InterestAndOtherIncomeNet
1000
CY2012Q2 usph Rent Clinic Supplies Contract Labor And Other
RentClinicSuppliesContractLaborAndOther
12992000
CY2012Q2 usph Corporate Office Costs
CorporateOfficeCosts
6396000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12110000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12110000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
21000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
12089000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12089000 shares
CY2013Q2 us-gaap Gross Profit
GrossProfit
17306000
CY2013Q2 us-gaap Profit Loss
ProfitLoss
7374000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
10684000
CY2013Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
1929000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10555000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
4914000
CY2013Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
65295000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
49918000
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
67224000
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2460000
CY2013Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1193000
CY2013Q2 us-gaap Interest Expense
InterestExpense
130000
CY2013Q2 us-gaap Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations
InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
0
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
201000
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
8000
CY2013Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
35813000
CY2013Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3181000
CY2013Q2 usph Interest And Other Income Net
InterestAndOtherIncomeNet
1000
CY2013Q2 usph Rent Clinic Supplies Contract Labor And Other
RentClinicSuppliesContractLaborAndOther
12904000
CY2013Q2 usph Corporate Office Costs
CorporateOfficeCosts
6622000

Files In Submission

Name View Source Status
0001193125-13-325579-index-headers.html Edgar Link pending
0001193125-13-325579-index.html Edgar Link pending
0001193125-13-325579.txt Edgar Link pending
0001193125-13-325579-xbrl.zip Edgar Link pending
d553338d10q.htm Edgar Link pending
d553338dex311.htm Edgar Link pending
d553338dex312.htm Edgar Link pending
d553338dex313.htm Edgar Link pending
d553338dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
usph-20130630.xml Edgar Link completed
usph-20130630.xsd Edgar Link pending
usph-20130630_cal.xml Edgar Link unprocessable
usph-20130630_def.xml Edgar Link unprocessable
usph-20130630_lab.xml Edgar Link unprocessable
usph-20130630_pre.xml Edgar Link unprocessable